Literature DB >> 14113229

OBSERVATIONS ON THE CLINICAL, CHEMICAL, AND SEROLOGICAL MANIFESTATIONS OF RHEUMATOID ARTHRITIS, BASED ON THE COURSE OF 154 CASES.

J T SHARP, E CALKINS, A S COHEN, A F SCHUBART, J J CALABRO.   

Abstract

Entities:  

Keywords:  ANKYLOSIS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; BLOOD CHEMICAL ANALYSIS; CLASSIFICATION; GAMMA GLOBULIN; HEXOSAMINES; RADIOGRAPHY; REVIEW; RHEUMATOID FACTOR; SERUM GLOBULINS; SPONDYLITIS; STATISTICS

Mesh：

Substances：

Year:  1964        PMID： 14113229     DOI： 10.1097/00005792-196401000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  12 in total

1.  Management of rheumatoid arthritis.

Authors:  S Carette
Journal:  Can Fam Physician       Date:  1984-06       Impact factor: 3.275

2.  CLINICAL SIGNIFICANCE OF THE L.E.-CELL PHENOMENON IN RHEUMATOID ARTHRITIS.

Authors:  L J GOLDFINE; M B STEVENS; A T MASI; L E SHULMAN
Journal:  Ann Rheum Dis       Date:  1965-03       Impact factor: 19.103

3.  Early rheumatoid disease. I. Onset.

Authors:  A Fleming; J M Crown; M Corbett
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

4.  Rheumatoid factor in hypertension.

Authors:  A Ebringer; A E Doyle
Journal:  Br Heart J       Date:  1973-03

5.  Juvenile rheumatoid arthritis. Cellular hypersensitivity and selective IgA deficiency.

Authors:  R S Panush; N E Bianco; P H Schur; R E Rocklin; J R David; J S Stillman
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

Review 6.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

7.  Prognostic value of early features in rheumatoid disease.

Authors:  A Fleming; J M Crown; M Corbett
Journal:  Br Med J       Date:  1976-05-22

8.  Rheumatoid nodules do not predict response to treatment with slow-acting anti-rheumatic drugs.

Authors:  G M Hall; A Studnicke; E C Huskisson; D L Scott
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

9.  Sulphasalazine and regression of rheumatoid nodules.

Authors:  H J Englert; G R Hughes; M J Walport
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

10.  The metabolism of autologous IgM and 19S rheumatoid factor in rheumatoid arthritis.

Authors:  J Bradley; D Normansell; D S Rowe
Journal:  Clin Exp Immunol       Date:  1969-05       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.